No content found

Sunday, April 10 | 4:00PM - 8:00PM
Registration
Arrival and Registration
Room: Colorado Ballroom Foyer


Sunday, April 10 | 6:00PM - 8:00PM
Welcome Mixer

Room: Colorado Ballroom Foyer
No registration fees are used to fund alcohol served at this function.

Monday, April 11 | 7:00AM - 8:00AM
Breakfast

Room: Summit Gallery


Monday, April 11 | 8:00AM - 9:00AM
Keynote Address
Welcome and Keynote Address
Introduction to the problem of multi-drug resistance in Plasmodium falciparum parasites in Southeast Asia, including a historical overview, treatment failures and current clinical approaches to treatment and prevention.

Arjen M. Dondorp, University of Oxford, Thailand
Malaria in Southeast Asia - Treatment, Control and the Impact of Mutlltidrug Resistance

Monday, April 11 | 9:00AM - 11:15AM
Plenary AM
Innovations in Antimalarial Drug Discovery
Room: Peaks 1-3
Presentations on screening approaches used to identify lead antimalarial compounds and their subsequent progression into antimalarial drug discovery programs.

Elizabeth A. Winzeler, University of California, San Diego, USA
Whole-Cell Parasite Screens for Active Compounds

Coffee Break

Jacquin C. Niles, Massachusetts Institute of Technology, USA
Regulating Gene Expression To Define Drug Mode of Action and Identify Target-Specific Chemotypes

Susan Wyllie, University of Dundee, UK
The Direct Approach: The Role of Chemical Proteomics in Anti-Malarial Target Deconvolution

Short Talks Chosen from Abstracts

Monday, April 11 | 11:15AM - 5:00PM
On Own for Lunch



Monday, April 11 | 11:15AM - 1:00PM
Poster Setup

Room: Peaks 4 & 5


Monday, April 11 | 1:00PM - 10:00PM
Poster Viewing

Room: Peaks 4 & 5


Monday, April 11 | 4:30PM - 5:00PM
Coffee Available

Room: Colorado Ballroom Foyer


Monday, April 11 | 5:00PM - 7:00PM
Plenary PM
Advancing Drug Discovery Efforts
Room: Peaks 1-3
Updates on innate drug discovery efforts that have reached human clinical trials. Also a review on principles of antimalarial pharmacology and the antimalarial drug discovery and development pipeline developed by the Medicines for Malaria Venture.

Jeremy N. Burrows, Medicines for Malaria Venture, Switzerland
The MMV Pipeline

Laura Sanz, GlaxoSmithKline, Spain
Global Health: Novel Therapeutic Options


Kelly Chibale, University of Cape Town, South Africa
Kinase Inhibitors for Malaria

Short Talks Chosen from Abstracts

Monday, April 11 | 7:00PM - 8:00PM
Social Hour with Lite Bites

Room: Peaks 4 & 5
No registration fees are used to fund alcohol served at this function.

Monday, April 11 | 7:30PM - 10:00PM
Posters
Poster Session 1
Room: Peaks 4 & 5


Tuesday, April 12 | 7:00AM - 8:00AM
Breakfast

Room: Summit Gallery


Tuesday, April 12 | 8:00AM - 11:00AM
Plenary AM
Experimental Models and Other Human Plasmodia
Room: Peaks 1-3
Will showcase screens developed to identify inhibitors of Plasmodium vivax hypnozoites. Will also present controlled human malaria infection models for P. vivax and P. falciparum and introduce new investigations into the human malaria parasite P. ovale.

John H. Adams, University of South Florida College of Public Health, COPH, USA
Large-scale Genetic Chemogenomic Screens to Elucidate Genotype-phenotype Relationships of P. falciparum Drug Responses

Flaminia Catteruccia, Harvard T.H. Chan School of Public Health, USA
Targeting Anopheles-Plasmodium Interactions

Coffee Break

James McCarthy, Peter Doherty Institute for Infection and Immunity, Australia
Pf Controlled Human Malaria Infection Models

Short Talks Chosen from Abstracts

Tuesday, April 12 | 11:00AM - 5:00PM
On Own for Lunch



Tuesday, April 12 | 11:00AM - 1:00PM
Poster Setup

Room: Peaks 4 & 5


Tuesday, April 12 | 1:00PM - 10:00PM
Poster Viewing

Room: Peaks 4 & 5


Tuesday, April 12 | 4:30PM - 5:00PM
Coffee Available

Room: Colorado Ballroom Foyer


Tuesday, April 12 | 5:00PM - 7:00PM
Plenary PM
Antimalarial Use and Drug Resistance
Room: Peaks 1-3
Review the global and regional spread of antimalarial drug resistance. Explore the genetic and mechanistic basis of resistance.

Didier Menard, Institut Pasteur Paris, France
The Global Spread of ART Resistance

Mallika Imwong, Faculty of Tropical Medicine, Mahidol university, Thailand
ACT Resistance in the GMS

David A. Fidock, Columbia University Medical Center, USA
Genetic Investigations Into Antimalarial Drug Resistance

Leann M. Tilley, University of Melbourne, Australia
Targeting Proteostasis for Antimalarial Drug Development

Short Talks Chosen from Abstracts

Tuesday, April 12 | 7:00PM - 8:00PM
Social Hour with Lite Bites

Room: Peaks 4 & 5
No registration fees are used to fund alcohol served at this function.

Tuesday, April 12 | 7:30PM - 10:00PM
Posters
Poster Session 2
Room: Peaks 4 & 5


Wednesday, April 13 | 7:00AM - 8:00AM
Breakfast

Room: Summit Gallery


Wednesday, April 13 | 8:00AM - 11:00AM
Plenary AM
Reducing the Burden of Malaria Part I
Room: Peaks 1-3
Review the global and regional spread of antimalarial drug resistance. Explore the genetic and mechanistic basis of resistance.

Thierry T. Diagana, Novartis Institute for Tropical Diseases, USA
Fostering the Pharmacological Diversity of Novartis Malaria Pipeline to Support Disease Elimination


Elizabeth A. Ashley, Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, UK
Update on TACTs

Coffee Break

Ric N. Price, Menzies School of Health Research, Australia
Novel Approaches for the Safe and Effective Radical Cure of P. Vivax

Short Talks Chosen from Abstracts

Wednesday, April 13 | 11:00AM - 5:00PM
On Own for Lunch



Wednesday, April 13 | 4:30PM - 5:00PM
Coffee Available

Room: Colorado Ballroom Foyer


Wednesday, April 13 | 5:00PM - 6:45PM
Plenary PM
Reducing the Burden of Malaria Part II
Room: Peaks 1-3
Review preventative strategies to reduce the burden of malaria, mostly in Africa. Talks will examine current treatment regimens in Africa, seasonal malaria chemoprevention, and intermittent preventive treatment in pregnancy. The session will also provide an overview of the use of modeling to inform interventions.

Philip J. Rosenthal, University of California, San Francisco, USA
Antimalarial Drug Efficacy and Resistance in Africa

Abdoulaye Djimde, University of Science, Techniques and Technologies, Mali
Reducing the Burden of Malaria: How Can Genomics Help?

Marielle K. Bouyou Akotet, Universite des Sciences de la Santé, Gabon
Perspectives on Malaria Control Programs in
Africa


Janice A. Culpepper, Bill & Melinda Gates Foundation, USA
Strategic Perspectives on Reducing the Burden of Malaria

Short Talks Chosen from Abstracts

Wednesday, April 13 | 6:45PM - 7:00PM
Plenary
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Peaks 1-3


Wednesday, April 13 | 7:00PM - 8:00PM
Social Hour with Lite Bites

Room: Peaks 4 & 5
No registration fees are used to fund alcohol served at this function.

Wednesday, April 13 | 8:00PM - 9:00PM
Cash Bar

Room: Peaks 4 & 5


Thursday, April 14 | 10:03AM - 10:03AM
Departure



*Session Chair
†Invited, not yet responded.

No content found

No content found

No content found